Contact – +91 9607683178
 Email –

Home >> Latest Press Release



Bio-Pesticides Market, By Type (Bio-Chemicals, Microbials, Plant Incorporated Protectants), Product (Bio-insecticides, Bio-Fungicides, Bioherbicides), Crop Type (Grains & Oilseeds, Fruits & Vegetables, Turf & Ornamental Grass)- Global Trends & Forecasts Upto 2023

The total bio-pesticides market was estimated at $ 3.2 billion in 2017. The market is expected to grow at a CAGR of 6.8% from 2017-2023 and is projected to reach $ 6.8 billion by 2023. An increase in population resulted in the rising demand for food. To maintain an optimum balance between food demand and supply, chemical pesticides have been extensively used. The harmful residues of these chemical pesticides have adversely affected the food chain. The use of synthetic pesticides has resulted in the contamination of food, water, and air. Bio-pesticides have risen as a viable eco-friendly alternative to synthetic or chemical pesticides. They are usually a less toxic substance than traditional synthetic pesticides. The support and encouragement of the USA Environment Protection Authority (EPA) for the use of environmentally friendly pesticides drive the market heavily. Bio-pesticides are formulated in a manner that they eliminate target pests and related organisms, which can damage vegetables and crops. In terms of types of products, bio-fungicides and bio-insecticides accounted for the largest market share in 2017. The impact of conventional insecticides is less effective due to increasing resistance among pests and insects. Crop and vegetable growers are inclined towards the usage of bio-insecticides, which is cost-effective and has convenient handling properties. The ban on certain chemical insecticides and fungicides provides an edge to the bioinsecticides and biofungicides market. The bio-nematicides segment is expected to grow at the fastest rate due to its increasing usage in oil seed protection. The quantity of bio-pesticides used in fruits and vegetables is more than any other crop type. Increasing food and vegetable production is one of the major reasons for bio-pesticides consumption globally. Bio-pesticides are extremely effective against microbial infections that damage fruit crops, which result in their increasing acceptance in the agriculture sector, globally. Other significant crop types are grains and oil seeds. In terms of modes of application, foliar spray was the most popular segment in 2017. Bio-pesticides directly applied to foliage ensures its strong impact on insects, pests, and bugs. North America accounted for the largest market share in 2017, followed by Europe and Asia-Pacific. The presence of a large number of organic farms, process centres & facilities, as well as vineyards and ranches boosts the usage of bio-pesticides in the region. The ban on certain chemicals and toxic insecticides & pesticides such as 1,3-Dichloropropene and neonicotinoid pesticides (France, Germany, Slovenia, and Italy) fuel the growth in Europe for bio-pesticides market. Companies are joining hands to develop new and innovative bio-pesticides solutions worldwide. In 2016, BASF signed a collaborative agreement with a start-up company-Plant Advanced Technologies (PAT). Under this agreement, PAT is expected to employ its "Plant Milking" and "Target Binding" technologies to identify probable bio-chemical candidates for novel pesticides. BASF is anticipated to use its proprietary advanced plant platform to screen candidates to experimentally validate their biological effects. Some of the major players that operate in the industry are BASF SE, The DOW Chemical Company, Monsanto Company, Marrone Bio Innovations Inc., Isagro SPA, Valent Biosciences Corporation, Certis Usa L.L.C., W. Neudorff GmbH Kg, Koppert B.V., Bioworks, Inc., and Camson Bio Technologies Limited. ...

 3/3/2018 |  Food & Beverage

Cenospheres Market, By Type (Gray, White), Density (Floating, Submerged), Formation type (Artificial, Coal Blues), End-use Industry (Construction, Oil & Gas, Refractory, Paints & Coatings & Others) – Global Market Trends & Forecasts Upto 2025

The cenospheres market is estimated to account for USD 409.0 million in 2017, and is projected to grow at a CAGR of 11.0% to reach USD 765.0 million by 2023. Cenospheres market is expected to grow bolstered by growth from end-use industries such as oil & gas, construction, and refractory and superior structural properties. Limited availability of raw material and lack of quality control across emerging countries are the major restraints observed in the cenospheres market. However, the challenge is capital and technological intensive nature of manufacturing process. The opportunities for players in this market lie in exploring methods for reclamation of fly ash lagoons. [<<img 4.png>>] The global cenospheres market can be classified into gray cenospheres and white cenospheres based on types. In 2017, gray cenospheres accounts for the largest share and is expected to continue leading the segment during the forecast period. The prime reason for their majority share is their higher abundance in fly ash as compared to white cenospheres. Gray cenospheres are said to posses’ high content of silica & iron and low content of alumina and finds many applications across plastics, coatings, and resins. The cenospheres market is also analyzed based on density. The cenospheres have been classified as floating cenospheres with density less than 1 gram per cm3, while those greater than 1 gram per cm3 are known as submerged cenospheres. With respect to formulation mode, cenospheres are classified as artificial cenospheres and coal blues cenospheres. The major end-use industries of cenospheres are oil & gas, refractory, construction, automotive, and paints & coatings, among others. In 2017, Oil & gas is projected to be the fastest-growing end-use industry segment of the market. This is owing to rising demand from increasing drilling operations in oil & gas segment in North America and the Middle East thus driving the demand for microspheres. In 201, North America accounts for the largest share of the total cenospheres market. Europe and Asia-pacific follows next with second and third rank, respectively. North America cenospheres market is also anticipated to register the highest CAGR during the forecast period. This is owing to the increasing demand from end-use industries such as oil & gas and automotive in the region due to superior characteristics such as low water absorption & thermal conductivity, resistance to acids, ultra-low density, and high particle strength thus improving the properties of finished products. Asia-Pacific cenospheres market is anticipated to register considerable growth during the forecast period due to increasing demand from the emerging economies (such as China, South Korea, and India) owing to technological innovations and strong foothold of the regional players. Amidst the technological and capital intensive nature of manufacturing process, to manage the costs and maintain the profits is an uphill task for all the players in the cenospheres market. In such a case, potential collaborations and leveraging the resources is the optimum strategy adopted by the market players. The key players in the cenospheres market are Ceno Technologies, Omya AG, Cenosphere India Pvt. Ltd., Durgesh Merchandise Pvt. Ltd., Reslab Microfiller, Cenostar, VIPRA, Scotash Limited, Petra India Group, PR Ecoenergy Pvt. Ltd., Qingdao Eastchem Inc., Envirospheres, and Delamin Limited among others. ...

 3/3/2018 |  Chemicals & Materials

Food Safety Testing Market, By Contaminants (Pathogens, Toxins, GMO's, Pesticides), Technologies (Chromatography, Culture Assay, Bio-Chips), End User (Meat & Poultry, Diary, Processed Food, Fruits & Vegetables) - Global Market Trends & Forecasts Upto 2023

Food Safety Testing Market The total food safety testing market is valued at USD 12.9 billion as on 2017 and is anticipated to reach USD 20 billion by the end of 2023, growing at a CAGR of 7.5%. The main growth driving factors include stringent international standards and regulation, improvements in food safety, performance and quality, continuous food inspection, and advances in food testing technologies. Factors like increasing incidences of foodborne illness, globalization of food supply chain management, easy accessibility of advanced Rapid Technologies and increasing awareness about chemical contamination in food industrial sector are the prime drivers that fuels the growth of the Global food safety testing market. In addition, the strict government rules and norms coupled with the increasing demand of ready to eat food products are also responsible in driving the need for testing of food products that are available in the market. However, the expensive cost of food safety testing services along with the lack of food safety infrastructure in developing regions are expected to hamper the growth of this market. Moreover, the long and time consuming testing processes, and lack of standardization in sample collection serves to be the major challenges of safety testing market. The growing consumer awareness about food safety and its methods coupled with the increasing count of capital investments are anticipated to create great opportunities for food safety testing market in the developing countries. The food safety testing market is segmented on the basis of contaminants, testing technologies, end users and region. On the basis of contaminants this market is further fragmented into the pathogens, toxins, genetically modified organisms (GMO), pesticides and others. The pathogen category for the elaborated into E. Coli, Campylobacter, Listeria, Salmonella and Other. Among which, the pathogen segment is expected to have the largest Market share in 2017; due to its major role in making the food toxic and degrading the food quality. Moreover, the increasing prevalence of foodborne illness and other conditions are further expected to propel the growth of this market. On the basis of testing technologies, the food safety testing market is classified into chromatography, culture media, rapid assays, emerging technologies, biosensors or biochips and others. Chromatography is expected to dominate the market during the forecast period, accounting to the increasing research and development activities, technical advancements in food safety processes and optimization of food testing methods. However, the applications of biosensors or biochips is further expected to create awareness about food safety measures and thus it is responsible for fueling the growth of food safety testing market. On the basis of end users the food safety testing market is fragmented into meat & poultry, dairy products, processed food, seafood, beverages, fruits & vegetables, and others. Processed foods led this market during the base years, but the increasing consumption of meat and poultry products is expect to hold the largest market share during the forecast. As meat and poultry products are more susceptible to contamination. However, the adoption of Hazard Analysis Critical Control Points or HACCP in slaughterhouse and processing plants prevents the contamination of food products and assures the delivery of quality food products to the consumers. On the basis of region, the food safety testing market is segmented into North America, Europe, Asia and Row. Overall, North America dominates this market, due to the presence of major players in this region, elevating count of population, adoption and implementation of strict norms to assure quality food products are some of the prime factors fuelling the growth of this market. In addition, the supportive government against food contamination coupled with the increasing count of working women is also elevating the need for packed and convenience food in the market, which is further increasing the demand of food safety testing. The leading major players in the market are Eurofins, SGS SA, Intertek Group PLC, Bureau Veritas S.A., ALS Limited, Microbac Laboratories, Inc, Bureau Veritas SA, Neogen Corporation, SCS Global Services, Microbac Laboratories, Laboratory Corporation of America Holdings, Mérieux Nutrisciences, Asurequality Ltd., Romer, Labs Division Holding GmbH, and Genetic ID NA, Inc. ...

 3/27/2018 |  Food & Beverage

Bio-Stimulants Market, Type (Cereals, Oilseeds, Turfs & Ornamentals, Fruits & Vegetables), Ingredient (Humic Acid, Fulvic Acid, Vitamins, Amino Acids), Application (Foliar Treatment, Seed Treatment, Soil Treatment) - Global Market Trends & Forecasts Upto 2023

Bio-Stimulants Market The total food safety testing market is anticipated to reach USD 3.6 billion by the end of 2023, growing at a CAGR of 10.8% from 2018-2023. The bio-stimulant market is majorly driven by the increasing adoption of eco-friendly and organic food products in the market. Some of the other factors contributing towards the growth are growing focus on enhancement of yield and productivity per hectare and implementation of precise farming. Additionally, the strong product portfolio and enhancement of market portfolio in developing region create great opportunities for bio-stimulants. However, the availability of substitutes, expensive research and development activities, lack of awareness among farmers and time consuming process hampers the growth of bio-stimulants market. Additionally, the adoption of plant phenotyping and focus on farm profitability are the major trending issues that are responsible for increasing the adoption of bio-stimulants by the farmers. The bio-stimulants market is segmented on the basis of crop type, form, active ingredients, applications and geography. On the basis of crop type, the market is further fragmented into cereals, oil seeds, turfs & ornamentals, fruits & vegetables and others. Among which, cereals segment has the largest market share, which is due to the increased production of food grains in order to feed the elevating population, adoption of sustainable farming practices due to the availability of limited land and water and the positive effect of bio-stimulants against abiotic stress. On the basis of form, the bio-stimulant market is categorized into dry and liquid bio-stimulant. The dry formulation of bio-stimulant is recorded to have largest market share in the base year. Factors like easy handling and transportation, improvement in photosynthesis coupled with lateral but development process, delaying of aging process of plant tissues and promotion of cell division and plant respiration activity results in increased demand of dry form of bio- stimulant in the market. The active ingredient category of bio-stimulants market is fragmented into humic acid, fulvic acid, trace minerals, seaweed extracts, microbial soil amendments, vitamins, amino acids, chitin & chitosan, protein hydrolysates, and others. The seaweed extracts segment holds the largest market share and is expected to grow with the same pace during the forecast years. It may be due to the benefits of extract based ingredients in terms of aeration and advanced soil structures, elevation of seed germination processes, and growing of biotic and abiotic tension resistant yield. On the basis of application, the bio-stimulant market is categorized into foliar treatment, seed treatment, soil treatment, potassic, and others. The foliar segment holds the largest market share, owing to the efficiency of foliar sprays for instant results, enhanced productivity factor, high rate of absorption and enhanced farming technologies. Geographically, the bio-stimulant market is divided into North America, Europe, Asia and ROW. Among all, Europe, followed by Asia, is expected to dominate this market. Factors like growing awareness about susceptible farming, increasing demand of important fruit and field crops, strict rules on environmental safety, and increasing capital investments in research and development activities are responsible and boosting the growth of bio-stimulants market. The key players operating in this industry are Arysta Life science Limited, Biolchim S.P.A., Biostadt India Limited, Isagro S.P.A., Italpollina S.P.A., Lida Plant Research S.L., Monsanto Company, Novozymes A/S, Syngenta Ag, and Valagro S.P.A. ...

 3/27/2018 |  Food & Beverage

Healthcare BPO Market by Services (Revenue cycle management, Patient enrollment, Medical coding, billing and collection services), by facility (Large health systems, Stand-alone hospitals, Ambulatory surgical centers) - Global Industry Trends & Forecasts Upto 2023

The healthcare BPO market is estimated to reach USD 330 billion by 2023 growing at a CAGR of 11.0 from 2018-2023. The healthcare BPO market is primarily driven by elevating cost-saving factor, growing perception for recovery audits coupled with increasing research and development activities. However, the service reliability issue along with the complications and concerns of data privacy may hamper the growth of this market. In addition, implementation of IT in Healthcare sector serve to be the growing opportunity for healthcare BPO market. The adoption of BPO services is also responsible for propelling the growth of the market. The healthcare BPO market can be segmented into payer services, provider services, and pharmaceutical services. The payer services can be further segmented into human resource management, claims management, Customer Relationship Management (CRM), operational/administrative management, product development, care management and provider management. The induced pressure to reduce elevating Healthcare expenditures, increasing demand of niche services, increasing demand of ICD-10 over ICD-9, adoption of automation and integrated sourcing strategies and demand and recovery audits are some of the prime factors responsible for propelling the growth of this market. The provider services of healthcare BPO market provider is further segmented into patient enrollment and strategic planning, medical billing, medical transcription, device monitoring and revenue cycle management. On the basis of provider service, revenue cycle management is expected to grow at a steady pace during the forecast period. The growing revenue cycle management market further counts to the decreasing reimbursements in the healthcare industry, resulting in the reduction of overall Healthcare expenditure coupled with supportive government policies fuels the growth of this segment in Healthcare BPO market. The Pharmaceutical segment of this market is further classified into manufacturing outsourcing, clinical data management, and pharmacovigilance services. Factors like increasing research and development activities, strict norms, adoption of IT in the healthcare sector, and upsurge demand in RCM plays a significant role in fueling the growth of the market. However, the lack of proper and accurate information and Communication Technology infrastructure coupled with interoperability issues and lack of domain expertise may restrict the growth of the market. Geographically, the healthcare BPO market segmented into North America, Europe, Asia, and ROW. On the basis of geography, North America dominates this market, accounting to the growing economic growth rate and increasing Healthcare expenditure throughout this region. This further resulted in increasing investments in Technologies responsible for simplifying the healthcare systems and services that further drive the growth of this market. Moreover, the adoption of BPO services in the healthcare industry, increase in medical transcription outsourcing services and adoption of cloud-based BPOs healthcare sector are for the responsible in creating great opportunities for this market. However, the increasing doubts over the quality of services, high attrition rate, and privacy concerns and data security issues may restrict the growth of the market. The key players operating in this industry are Accenture, Tata Consultancy Services, Genpact, Boehringer Ingelheim GmbH, Cognizant, Charles River Laboratories International Inc., Covance Inc., Infosys Limited, Lonza Group Ltd. and Quintiles Inc. ...

 3/27/2018 |  Healthcare

eClinical solutions Market By Product (Electronic Data Capture and Clinical Data Management Systems Clinical Trial Management Systems), By (Phase I, Phase II, Phase III, Phase IV)-Global Trends & Forecasts Upto 2023

The e-clinical solutions market is estimated to account for USD X.X billion in 2017, and is projected to grow at a CAGR of X.X% to reach USD X.X billion by 2023. The market is majorly driven by the increasing count of clinical trials, rising number of government funding for such trials, growing need for improved data standardization, regulatory requirements associated with clinical research studies and increasing research and development of activities by pharmaceutical and biotechnology based companies. In addition, the adoption of global software solutions in clinical research studies, access data mounting from Healthcare industry and the presence of wide and strong range of products in the pipeline are another factors that boost the growth of this market. However, the lack of awareness about the benefits of a clinical solution coupled with the infrastructure of these solutions are the prime factors hindering the growth of the market. Additionally, the lack of skilled professionals and high implementation cost associated with the e-clinical solution software also restricts the demand for e-clinical solutions. Moreover, the factors like growing clinical Research activities in developing region coupled with the outsourcing of clinical trial processes are expected to create more opportunities for this market. But, the software reliability issues and patient privacy concerns still serves to be the major challenges of e-clinical solutions market. The e-clinical solutions market is segmented on the basis of product, type, delivery model, phase of clinical trials, end-users and region. On the basis of products, the market is fragmented into Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, Biostatistics and statistical programming solutions, Data conversion and standardization solutions, Electronic patient reported outcome solutions, e-clinical integration solutions, and Other e-clinical Solutions. On the basis of types, the e-clinical solutions market is categorized into standalone and integrated systems. Whereas on the basis of delivery models, this market is fragmented into on-premises e-clinical solutions and on-demand or cloud-based e-clinical solutions. The on-demand e-clinical solution segment is growing at a faster rate, accounting to the increasing applications of internet of things, real time study management, adoption of standard and ad hoc reporting, etc. On the basis of phase of clinical trials, this market is categorized into Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, and Phase IV Clinical Trials. Whereas, the end-user category comprises of pharmaceutical and bio-pharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, and hospitals. Among all, the pharmaceutical and bio-pharmaceutical companies is expected to dominate this market, owing to the increasing research and development activities for new product development, adoption of a centralized place to carry out all the trials related information and the improvement in clinical data management by the involvement of staff and data administrators. Geographically, the market is segmented into North America, Europe, Asia and ROW. North America dominate this market, accounting to the elevating count of clinical trials, increasing research and development activities for the development of new product, supportive government policies and changing lifestyles. However, the Asian region is also reported to have a steady growth rate during the forecast years, owing to the increasing research and development activities in this region. The key players operating in this industry are BioClinica, CRF Health, Datatrak International, Inc., Medidata Solution, Inc., Merge Health Incorporated, OmniComm Systems Inc., Oracle Corporation, and Parexel International Corporation. ...

 3/27/2018 |  Healthcare

Healthcare Analytics Market, Type (Prescriptive, Predictive, Diagnostic), Component (Hardware, Software, Services), Application (Financial, Clinical, Population Health Management), End- User (Payers, Providers, ACOS) - Global Market Trends & Forecasts upto 2023

The healthcare analytics market is estimated projected to grow at a CAGR of 28.0 % to reach USD billion by 2023. High adoption rates of electronic health record systems coupled with the application of big data in healthcare and increasing investment expenditures in healthcare industry is also boosting the growth of healthcare analytics market. However, the lack of skilled IT professionals coupled with the penetrating data integrity issues are the major restraints of healthcare analytics market. In addition, the implementation and applications of electronic health records, focus on value-based medicines and growing adoption of cloud-based analytics serve to be the prime opportunities for this market. The healthcare analytics market can be segmented on the basis of type, component, delivery mode, application, and end-user. On the basis of type, the healthcare analytics market can be segmented into descriptive analytics, diagnostic analytics, predictive analytics, and prescriptive analytics. The descriptive analytics segment, on the basis of types of healthcare analytics market, is reported to have the largest market share, owing to the increasing supportive and favorable healthcare policies that are launched by the government, progressive outcomes of clinical processes and the positive impact of social media on the healthcare industry. On the basis of components, the healthcare analytics market can further be segmented into services, software, and hardware. The services segment is further categorized as support services and business analytics services; whereas the software segment is further divided into standalone and integrated. Based on components of Healthcare analytics market, the services segment holds the largest market share accounting to the elevating need for business analytics services coupled with the advancements in technical healthcare analytics software. In addition, the emerging requirement of personalized and evidence-based medicine is also responsible for increasing the demand for service-based healthcare analytics software in the market. On the basis of delivery mode, this market is further categorized as on-premise healthcare analytics and on-demand /cloud healthcare analytics. On the basis of the delivery model of healthcare analytics market, the on-demand healthcare analytics segment is expected to grow at a steady pace; accounting to the higher flexibility, upsurge need for self-driven analytics, and pay-as-you-go cost factor. Moreover, the lack of increasing capital investments in the healthcare sector is also responsible for fuelling the growth of this market. On the basis of application, the market is fragmented into financial analytics, clinical analytics, operational and administrative analytics, and population health management/analytics. On the basis of applications of Healthcare Analytics market, operational and Administrative Services dominated this market in 2015, accounting to the elevated count of application including strategic Analytics, supply chain management and workforce. However, the financial applications are also expected to have an anticipated growth during the forecast, owing to the increasing adoption of Healthcare analytics in both governments as well as private healthcare departments. Lastly, on the basis of end-users, the healthcare analytics market is segmented into payers, providers, ACOS, HIES, MCOS, and TPAS, and third-party business analytics service providers. On the basis of end users, the payers segments are expected to dominate this market during the forecast years, accounting to the involvement and application of these services quality improvement, population health management, and personalized care. However, the increasing efficiency in Healthcare sector coupled with the reduction in the unnecessary and unwanted expenditure is also responsible for dominating this segment. Geographically, the market is divided into North America, Europe, Asia, and ROW. Geographically, North America dominates the Healthcare analytics market followed by Europe and Asia; accounting to the technological advancements in Healthcare services, implementation of regulatory clauses, and increasing government incentives that are focusing on the manufacturing and applications of personalized and customized medicines. However, the expensive nature of analytics software and services, increasing data integrity issues, the complexity of software and intensified competition may hamper the growth of Healthcare analytics market. The key players operating in this industry are Cognizant, Health Catalyst, IBM, Mede Analytics, Inc., MedAssets, Inc., McKesson Corporation, Optum, Oracle, Inc., SAS Inc., Truven Health Analytics, and Verisk Health. ...

 3/27/2018 |  Healthcare

Infection Control Market By Type (Disinfectants, Sterlization, Medical Non-Wovens, Disinfectors), End-User (Hospitals, Medical Devices, Pharmaceuticals, Life Science Industry, Clinical Laboratories, Food Industry - Global Market Trends & Forecasts Upto 2023

The Infection Control market is estimated 25 billion by 2025 growing at a CAGR of 6.0 % from 2018-2025. Factors like increasing prevalence of hospital acquired infections, elevating count of surgical procedures, strict safety norms and regulations, and technical advancements in sterilization processes search to be the driving factors of this market. However, sterilization of advanced medical instruments and increasing concern related to safety of reprocessed instruments hamper the growth of this market. Additionally, high adoption rate of E-beam sterilization and merger of pharmaceutical and medical device manufacturer are also boosting the growth of the infection control market, globally. Moreover, the non-compliance issues by the end users with respect to the sterilization standards is the prime challenging factor for this market. The infection control market is segmented on the basis of products & services, end user and geography. On the basis of products & services, the market is further fragmented into sterilization products and services, disinfectants, medical non-woven and disinfector. Among all, the disinfection segment holds the largest market share, owing to the growing application of infection control systems in hospitals, the growing need for reduction of cross contamination in food and Pharmaceutical sectors and the high adaptability rate of skin and hand disinfectants. Additionally, the infection control market is also segmented on the basis of end-user, as hospitals, medical device companies, pharmaceutical companies, life science industry, clinical laboratories, food industry and others. Hospital segment dominates this market, accounting to the increasing prevalence of hospital acquired infections, elevating health related expenditures due to the increasing count of elderly population and chronic diseases. Moreover, the threat of infectious diseases like AIDS, Ebola and antivirus in the last 3 decades is also responsible in fueling the growth of the market. On the basis of geography, North America dominates this market, followed by Europe, Asia and ROW. The increasing demand for infection control products, growing awareness about hygiene and infection free environment coupled with increasing count of surgical processes also plays an important role in propelling the growth of infection control market in North America. In addition, the supportive government policies, changing lifestyles and growing geriatric population further increases the demand for infection control systems. Asian region is also expected to have a study growth during the forecast years, accounting to the growing economies of developing countries like India and China, increasing prevalence of nosocomial infections coupled with the improvement and expansion of healthcare infrastructure of this region. However, the growing outsourcing trend by the established key players of developed regions to the company's present in Asian regions is also responsible in boosting the growth of infection control market. The key players operating in this industry are 3M Company, Ahlstrom Corporation, Belimed AG, Cisa S.p.A, Getinge Group, Honeywell International, Inc., Johnson & Johnson Limited, Kimberly-Clark Corporation, Matachana Group, Nordion Inc., Sakura Global Holding Company Ltd., Sterigenics International, Inc., STERIS Corporation, Synergy Health plc, and TSO3 Inc. ...

 3/27/2018 |  Healthcare

Software Defined Everything Market By Type (Software-Defined Networking, Software Defined Data Centre, Software Defined Computing, Software Defined Storage), Services (Managed, Consulting, Integration and Deployment), Vertical (IT, Telecom, Healthcare, BFSI, Manufacturing, Logistics) - Global Trends & Forecasts Upto 2025

Software Defined Everything (SDE) specifies the shift of technology in software defined way for accessing the storage, networks and data centers. The main function of SDE is to reduce the silos in the market. Software defined everything is segmented on the basis of type and application. The type segment is further bifurcated into SDN, SDS and SDDC. SDN offers a great amount of flexibility and more control over the programs and how the data packets and traffic travels across your network. Cloud Computing plays vital role in the development and growth of SDE and SDN (Software defined networking). Many IT companies are adopting cloud computing in the network infrastructure for the better and efficient management. SDN helps in allowing the cloud service providers to host multiple number of virtual networks without any need of common separation isolation methods. The SDE Market is expected to grow at a CAGR of 28% during the forecast period 2017–2023. The SDE market is driven by IoT and cloud computing adoption across industry verticals such as BFSI, aerospace & defense, retail, food & beverages, healthcare and automotive. The major players included in this report are Dell, HPE, VMware, Extreme Networks, Nexenta Systems, Riverbed Technology, Silver Peak, Metaswitch Networks, Pivot3, Infoblox and others. This report offers major trends, industry trends which is going to play a major role in SDE market during the forecasted year. Moreover, this report can also tailored as per the requirement by the users, and also available with deeper segmentation by regions, countries, and vendor profiling. ...

 3/27/2018 |  ICT

District Cooling Market, By Technique (Free Cooling, Electric Chiller, Absorption Cooling), Application (Residential, Commercial, Industrial) - Global Market Trends & Industry Forecasts Upto 2023

The total district cooling market is valued at $ 5.6 billion as on 2018 and is likely to reach $ 10.23 billion by the end of 2023, growing at a CAGR of 14.1%. The district cooling market is will bolstered as it offers various benefits such as it helps in capital cost savings by 8%, around 50% reduction of electric power consumption and reduction of CO2 and refrigerant emissions by 60-70% and good operational efficiency as compared to other cooling technologies when it used in highly dense areas. The factors driving the district cooling market are energy efficient cooling technology. Recently, United Nations has considered district cooling as the most energy efficient technology as it aids in preserving energy and water. The major issues faced in this market are risk of early investments, and initial high capital costs. In 2018, the district cooling market is dominated by Middle East & Africa market followed by North America and then Asia-Pacific. The Middle East will experience the highest growth rate during the forecast period as district cooling offers various advantages such as high cooling density, more cost efficient than conventional cooling, more energy efficient, no harmful impact on the environment. By 2030, if district cooling is properly employed, then it can fulfill 30% cooling needs of GCC countries. The district cooling market has been segmented on the applications i.e. residential, commercial and industrial. In 2018, the residential segment will experience high growth in the next five years where as commercial segment will account for the highest growth rate. The commercial segment will experience the highest growth rate due to increasing demand of district cooling in hotels, molls etc. The growth in district cooling market is influenced by investments and major expansion plans. In 2018, UAE based National Central Cooling Company (Tabreed) and the Masdar Institute of Science and Technology, completed three years R& D project in district cooling plant. Some of the prominent players in the market are Empower, National Central Cooling Company PJSC (Tabreed), Semens AG, District Cooling Company LLC, Qatar Coolol, Danfoss District Energy A/S, ADC ENERGY SYSTEMS LLC, Keppeldchs PTE Ltd, Marafeq Qatar, Logstor. ...

 3/2/2018 |  Chemicals & Materials